Ganetespib for small cell lung cancer. - Wikidata - awgldk - TriplyDB

Ganetespib for small cell lung cancer.

Ganetespib for small cell lung cancer.

http://www.wikidata.org/entity/Q38786678

about

Ganetespib for small cell lung cancer.

http://www.wikidata.org/entity/Q38786678

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ganetespib for small cell lung cancer.

@en

type

label

Ganetespib for small cell lung cancer.

@en

prefLabel

Ganetespib for small cell lung cancer.

@en

P1433

Q38786678-80A2E05B-2752-4017-B910-EF824924FA82

P1476

Q38786678-8AE6A508-6185-42AC-B1E8-B8A2902FAC29

P2093

Q38786678-4BC1AAE6-8068-4D48-90DA-5B724CA386ED

Q38786678-A9B5F431-BCB4-4F63-AFF3-326007BFFF67

P2860

Q38786678-0182B063-FE3A-4714-992E-29F0CCB98153

Q38786678-0B961CCF-F3A2-4642-811E-C03886977522

Q38786678-0EE34266-613D-4400-983D-916EE8A865AB

Q38786678-1D57746B-08B5-48B4-B89D-CD9B90B5174A

Q38786678-21093B0E-31DC-40F9-B20B-80BAC880E1A8

Q38786678-213F7B25-2580-47EA-A442-43DAD6A90B94

Q38786678-46203126-5F37-4320-9BF0-8C1CDBAC42F3

Q38786678-5061335F-3968-4042-8D44-6106ADD8A4CC

Q38786678-506E0C86-07C8-4579-9FAE-2370233CE4DD

Q38786678-52E24119-E66C-46D9-8F34-85AABB75FFE6

P304

Q38786678-2DC747BE-0F8A-4451-9629-E0A9B8496454

P31

Q38786678-EA3EE55A-FE99-4AB8-B47B-68120EC48B63

P356

Q38786678-90BFB048-CCDC-46B5-B6FC-872A45C8A95C

P407

Q38786678-6A633D27-9729-49E8-AC1F-0B1739128B2A

P433

Q38786678-EEB32E89-1E60-4402-870F-7124D31A51F6

P478

Q38786678-EF1533CB-0C6A-4BB7-BAC8-7B301CA32214

P50

Q38786678-AEC58C45-9DCC-4B6E-A404-3816C6D803DF

P577

Q38786678-047FC388-51B1-480A-AFE1-85630BA3708C

P698

Q38786678-5223EEFC-7B2A-44FA-8D4C-EB379E3B8A00

P356

13543784.2017.1268599

P1433

Expert Opinion on Investigational Drugs

P1476

Ganetespib for small cell lung cancer.

@en

P2093

Deepa S Subramaniam

http://www.w3.org/2001/XMLSchema#string

Eiran A Warner

http://www.w3.org/2001/XMLSchema#string

P2860

Lung cancer: epidemiology, etiology, and prevention

Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501

PU-H71: An improvement on nature's solutions to oncogenic Hsp90 addiction

Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone.

Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation

The Hsp90 chaperone machinery: conformational dynamics and regulation by co-chaperones

Targeting the dynamic HSP90 complex in cancer

Multifaceted intervention by the Hsp90 inhibitor ganetespib (STA-9090) in cancer cells with activated JAK/STAT signaling

Structure and mechanism of the Hsp90 molecular chaperone machinery

Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.

P304

103-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13543784.2017.1268599

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Giaccone

P577

2016-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27922280

http://www.w3.org/2001/XMLSchema#string